Client Programs (e.g., STORM Therapeutics collaboration)
Various (Oncology, CNS, Metabolic, Immunology)
Discovery to Pre-clinical CandidateActive
Key Facts
Indication
Various (Oncology, CNS, Metabolic, Immunology)
Phase
Discovery to Pre-clinical Candidate
Status
Active
Company
About Sygnature Discovery
Sygnature Discovery is a prominent private UK-based CRO founded in 2011, offering fully integrated drug discovery services for biopharma clients. Its business model is centered on providing scientific expertise and a comprehensive technology platform to de-risk and accelerate external R&D programs, primarily in small molecules. The company is revenue-generating, with a demonstrated ability to deliver candidates rapidly, as evidenced by an 18-month case study with STORM Therapeutics. Its competitive edge lies in its integrated, co-located teams and a broad suite of capabilities spanning computational design, bioscience, chemistry, DMPK, and in vivo pharmacology.
View full company profile